Threshold Pharmaceuticals (NASDAQ:THLD) earned a $20 million milestone payment from Merck KGaA (PINK:MKGAF).The payment was related to performance of its TH-302 pancreatic cancer treatment candidate in a Phase 2 trial.
Threshold Pharmaceuticals (NASDAQ:THLD) earned a $20 million milestone payment from Merck KGaA (PINK:MKGAF).The payment was related to performance of its TH-302 pancreatic cancer treatment candidate in a Phase 2 trial.
